Pedro Huertas
Corporate Officer/Principal bei Mirror Neuron Systems LLC
Profil
Pedro Huertas is currently the Managing Director at Mirror Neuron Systems LLC since 2005.
He previously held positions as the Chief Development Officer at Amicus Therapeutics, Inc., Astellas Institute for Regenerative Medicine, Sentien Biotechnologies, Inc., and Inozyme Pharma, Inc. He also served as the Chief Medical Officer at Eloxx Pharmaceuticals, Inc. from 2015 to 2018.
Dr. Huertas received his undergraduate degree from Harvard University and Stanford University, his doctorate from Harvard Medical School, and his graduate degree from MIT Sloan School of Management.
Aktive Positionen von Pedro Huertas
| Unternehmen | Position | Beginn |
|---|---|---|
| Mirror Neuron Systems LLC | Corporate Officer/Principal | 01.01.2005 |
Ehemalige bekannte Positionen von Pedro Huertas
| Unternehmen | Position | Ende |
|---|---|---|
| INOZYME PHARMA, INC. | Technik-/Wissenschafts-/F&E-Leiter | 02.02.2021 |
Sentien Biotechnologies, Inc.
 Sentien Biotechnologies, Inc. BiotechnologyHealth Technology Sentien Biotechnologies, Inc. develops cell-based therapy for critical care. It provides the Sentinel, a device that actively treats patients during a dialysis dose by supplementing patient blood with MSC-derived secretions. The company was founded by Brian Miller and Biju Parekkadan and is headquartered in Lexington, MA. | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2019 |
| ELOXX PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2018 |
| OCATA THERAPEUTICS INC | Corporate Officer/Principal | 29.10.2007 |
| AMICUS THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Ausbildung von Pedro Huertas
| Harvard University | Undergraduate Degree |
| Stanford University | Undergraduate Degree |
| Harvard Medical School | Doctorate Degree |
| MIT Sloan School of Management | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| AMICUS THERAPEUTICS, INC. | Health Technology |
| INOZYME PHARMA, INC. | Health Technology |
| ELOXX PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Astellas Institute for Regenerative Medicine
 Astellas Institute for Regenerative Medicine Pharmaceuticals: MajorHealth Technology Astellas Institute for Regenerative Medicine engages in the development and commercialization of human pluripotent stem cell technology in the field of regenerative medicine. The company also have a preclinical development pipeline in areas outside of ophthalmology, including; autoimmune diseases, inflammatory diseases, and wound healing. The company was founded on May 18, 2000 and is headquartered in Marlborough, MA. | Health Technology |
| Mirror Neuron Systems LLC | |
Sentien Biotechnologies, Inc.
Sentien Biotechnologies, Inc. BiotechnologyHealth Technology Sentien Biotechnologies, Inc. develops cell-based therapy for critical care. It provides the Sentinel, a device that actively treats patients during a dialysis dose by supplementing patient blood with MSC-derived secretions. The company was founded by Brian Miller and Biju Parekkadan and is headquartered in Lexington, MA. | Health Technology |
